Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2024EP EuropaceOpen Access

Ventricular arrhythmia events in patients with implantable cardioverter-defibrillator before and after the treatment with sodium-glucose co-transporter 2 inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

MSM Giannotti SantoroUniversity of PisaAVA VecchiOspedale di LivornoFLFederica LapiraUniversity of Pisa

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Santoro et al. (2024) studied this question.

synapsesocial.com/papers/68e6c841b6db643587646d3chttps://doi.org/10.1093/europace/euae102.830
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1VENTRICULAR ARRHYTHMIA EVENTS IN PATIENTS WITH IMPLANTABLE CARDIOVERTER–DEFIBRILLATOR BEFORE AND AFTER THE TREATMENT WITH SODIUM–GLUCOSE CO–TRANSPORTER 2 INHIBITORS2024
  2. 2More Disease, Fewer Arrhythmic Events: A Competing‐Risk Signal for SGLT2 Inhibitors in ICD Recipients2026 · 1 citations
  3. 3EFFECT OF SGLT2 INHIBITORS ON THE ARRHYTHMIC BURDEN IN HEART FAILURE2024 · 1 citations
  4. 4Impact of SGLT2 Inhibitors on Device-Detected Arrhythmias: a Preliminary Study2025 · 1 citations
  5. 5Effect of sodium-glucose cotransporter 2 inhibitors (SGLT2) on the occurrence of tachyarrhythmias in patients with heart failure with reduced ejection fraction2026